loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of manufacturers, suppliers & exporters who supply chemical intermediates & fine chemicals related to Levamisole Hydrochloride

    Client Email Product
    Menu

    Levamisole Hydrochloride

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Polpharma (1)

    filter

    01 4816-80-2 (1)

    filter

    01 Poland (1)

    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Polpharma

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
    Contact Supplier Contact Supplier
    Flag Poland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-(p-toluenesulfonyl)-l-glutamic acid

    PDF Supplier PDF
    URL Supplier Web Content
    4816-80-2
    Levamisole
    Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer,...
    Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Production of HPAPI with an OEL value of 10 ng/m3 (OEB 6). The HP API investment includes separate process laboratories (PDL), analytical laboratories (ADL) with the possibility of performing QC analyses, and a GMP kilo-lab production line with volume up to 1.5 kg with potential volume increase.
    Polpharma CB

    BOS Basel 2024

    Attending

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY